Cancer Diagnostics Opportunity Predictive BioSciences specializes in molecular diagnostic tests for cancer diagnosis and monitoring, presenting a direct sales path to hospitals, oncology clinics, and pathology labs seeking advanced diagnostic solutions.

SMB to Mid-Market With 51-200 employees and annual revenue in the low millions, prioritize mid-sized healthcare networks and regional cancer centers that may be seeking scalable diagnostic services and laboratory solutions.

Physician Focus Target physician-facing stakeholders and laboratory directors who need reliable, timely diagnostic results to inform treatment plans, leveraging Predictive BioSciences’ emphasis on physician needs.

Growth Readiness As a growing biotech company with room to scale, offer collaboration on clinical validation, payer strategies, and potential co-development of tests to accelerate market adoption.

Competitive Positioning Position as a specialized cancer diagnostic partner with a focus on actionable insights and laboratory solutions, differentiating from broader biotech peers with limited diagnostic scope.